All Stories

  1. VALIDATE: Exploiting the synergy between complex intracellular pathogens to expedite vaccine research and development for tuberculosis, leishmaniasis, melioidosis and leprosy

    Article • F1000Research, April 2018, Faculty of 1000, Ltd.

    Dr Helen A Fletcher, Mitali Chatterjee

  2. High monocyte to lymphocyte ratio is associated with impaired protection after subcutaneous administration of BCG in a mouse model of tuberculosis

    Article • F1000Research, March 2018, Faculty of 1000, Ltd.

    Dr Helen A Fletcher, Matthew Gibb, Andrea Zelmer, Ayad Eddaoudi

  3. The convergent epidemiology of tuberculosis and human cytomegalovirus infection

    Article • F1000Research, March 2018, Faculty of 1000, Ltd.

    Dr Helen A Fletcher

  4. Social determinants and BCG efficacy: a call for a socio-biological approach to TB prevention

    Article • F1000Research, February 2018, Faculty of 1000, Ltd.

    Dr Helen A Fletcher

  5. World TB Day 2018: The Challenge of Drug Resistant Tuberculosis

    Article • F1000Research, February 2018, Faculty of 1000, Ltd.

    Dr Helen A Fletcher

  6. Status of TB vaccine development

    Article • F1000Research, February 2018, Faculty of 1000, Ltd.

    Dr Helen A Fletcher, Stefan Kaufmann, Gerald Voss

  7. Sleeping Beauty and the Story of the Bacille Calmette-Guérin Vaccine

    Article • mBio, August 2016, ASM Journals

    Dr Helen A Fletcher

  8. TRANSVAC workshop on standardisation and harmonisation of analytical platforms for HIV, TB and malaria vaccines: ‘How can big data help?’

    Article • Vaccine, July 2014, Elsevier

    Dr Helen A Fletcher, Stefan Kaufmann